Additional file 1 of Construction of a risk stratification model integrating ctDNA to predict response and survival in neoadjuvant-treated breast cancer

Additional file 1: sTable 1. The pCR rate in different molecular subtype. stable 2. Patient Clinical Characteristics (Train and Test Datasets). stable 3. Patient Clinical Characteristics (Extra Test Datasets). stable 4. Patient SNV Characteristics (Train and Test Datasets). stable 5. Patient CNV Characteristics (Train and Test Datasets). stable 6. significant SNV and CNV. stable 7. Patient ctDNA Characteristics.

补充材料1：
1. 补充表（sTable）1：不同分子亚型的病理完全缓解（pathological complete response，pCR）率
2. 补充表（sTable）2：患者临床特征（训练集与测试集）
3. 补充表（sTable）3：患者临床特征（额外测试集）
4. 补充表（sTable）4：患者单核苷酸变异（Single Nucleotide Variant，SNV）特征（训练集与测试集）
5. 补充表（sTable）5：患者拷贝数变异（Copy Number Variant，CNV）特征（训练集与测试集）
6. 补充表（sTable）6：显著单核苷酸变异与拷贝数变异
7. 补充表（sTable）7：患者循环肿瘤DNA（circulating tumor DNA，ctDNA）特征